Intrahepatic Cholestasis Clinical Trials

1 recruiting

Intrahepatic Cholestasis Trials at a Glance

10 actively recruiting trials for intrahepatic cholestasis are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Bologna, Barcelona, and Aurora. Lead sponsors running intrahepatic cholestasis studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, Ipsen, and Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico.

Browse intrahepatic cholestasis trials by phase

Treatments under study

About Intrahepatic Cholestasis Clinical Trials

Looking for clinical trials for Intrahepatic Cholestasis? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Intrahepatic Cholestasis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Intrahepatic Cholestasis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain

PFIC - Progressive Familial Intrahepatic Cholestasis
Ipsen150 enrolled10 locationsNCT07191704
Recruiting

A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

Progressive Familial Intrahepatic Cholestasis
Ipsen10 enrolled3 locationsNCT07185919
Recruiting
Not Applicable

DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE

Cholestatic Liver DiseaseProgressive Familial Intrahepatic Cholestasis
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico60 enrolled1 locationNCT07317193
Recruiting

A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)

Progressive Familial Intrahepatic Cholestasis (PFIC)Alagille Syndrome (ALGS)
Takeda50 enrolled1 locationNCT07293897
Recruiting

Serum Bile Acid Profiles in Patients With Intrahepatic Cholestasis of Pregnancy

Intrahepatic Cholestasis of Pregnancy
Jena University Hospital74 enrolled1 locationNCT07428226
Recruiting

Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

Progressive Familial Intrahepatic CholestasisAlagille Syndrome
Mirum Pharmaceuticals, Inc.70 enrolled8 locationsNCT06193928
Recruiting

Prospective Analysis of the Treatment of Progressive Familial Intrahepatic Cholestasis (TreatFIC)

Progressive Familial Intrahepatic Cholestasis
University Medical Center Groningen200 enrolled1 locationNCT06778174
Recruiting

Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis

Hepatobiliary CancerCholestatic Liver DiseaseIntrahepatic Cholestasis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna300 enrolled2 locationsNCT06781242
Recruiting

Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers

Hepatobiliary CancersProgressive Familial Intrahepatic Cholestasis (PFIC)Cholestatic Liver Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna600 enrolled5 locationsNCT06777914
Recruiting
Phase 4

Trial of URsodeoxycholic acid versus RIFampicin in severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC study

Severe early-onset intrahepatic cholestasis of pregnancy
University of Adelaide108 enrolled13 locationsACTRN12618000332224